Not Tagged
Not Tagged
['myeloid', '#myelof']
pharmaxis (#asx: $pxs) is pleased to feature at the conference, providing clinical evidence on the disease modifying effect of its pan lox inhibitor pxs 5505 in #myelofibrosis, and other myeloid neoplasms. view the media release: 
A clinical stage pharmaceutical company with approved products in world markets. Leaders in drug discovery for diseases linked to fibrosis and inflammation.